Related Experiment Video
Updated: Jul 18, 2026

09:43
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Hb Jambol: a new hyperunstable hemoglobin causing severe hemolytic anemia.
G D Efremov1, L Simjanovska, D Plaseska-Karanfilska
1Research Center for Genetic Engineering and Biotechnology, Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia. gde@manu.edu.mk
Acta Haematologica
|November 11, 2006
Summary
A novel hyperunstable hemoglobin variant, Hb Jambol, was identified in a Bulgarian child with severe hemolytic anemia. This variant resulted from a complex genomic rearrangement in the beta-globin gene.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Hemoglobinopathies are a group of inherited blood disorders affecting hemoglobin synthesis.
- Beta-thalassemia and related disorders are often caused by mutations in the beta-globin gene.
- Accurate molecular diagnosis is crucial for understanding disease mechanisms and patient management.
Observation:
- A de novo mutation causing a hyperunstable beta-chain variant (Hb Jambol) was identified in a 2-year-old Bulgarian girl.
- The patient presented with severe hemolytic anemia, indicating significant disruption of red blood cell function.
- RNA/DNA analysis revealed a complex genomic rearrangement involving insertions and deletions within the beta-globin gene locus.
Findings:
- The genomic rearrangement resulted in a deletion of 4 amino acids and an insertion of 9 amino acids at positions 105-108 of the beta-chain.
- This alteration created an elongated beta-chain of 151 amino acids, leading to extreme instability.
- The specific rearrangement involved a 23-nucleotide insertion, a 310-nucleotide deletion, and a 28-nucleotide insertion derived from an inverted sequence.
Implications:
- This case highlights the diverse and complex mechanisms underlying hemoglobinopathies.
- The identification of Hb Jambol expands the spectrum of known beta-globin gene mutations.
- Understanding such complex rearrangements is vital for genetic counseling and potential therapeutic strategies.
Related Concept Videos
Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
